RecallDepth
Class II Terminated

Ketorolac Tromethamine Injection, USP 60 mg/2 mL (30 mg/mL), packaged in 2 mL Single Dose Vials (NDC 0641-6043-01), 25 vials/shelf-pack (NDC 0641-6043-25), For IM Use Only, Rx only, Manufactured by: WEST-WARD Eatontown, NJ 07724 USA.

This recall has been terminated (originally issued January 22, 2020).

Company
Hikma Pharmaceuticals Usa Inc.
Recall Initiated
December 17, 2019
Posted
January 22, 2020
Recall Number
D-0658-2020
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
25,817 shelf packs/25 vials per pack
Firm Location
Cherry Hill, NJ, United States
Official Source
View on FDA website ↗

Reason for Recall

Presence of Particulate Matter: particles identified as polydimethylsiloxane (PDMS)

Distribution

Nationwide within the United States

Lot / Code Info

038368, Exp. Mar 2020; 058314, Exp. May 2020; 078305, 078307, Exp. July 2020; 118362 Exp. Nov 2020

More recalls by Hikma Pharmaceuticals Usa Inc.

View all recalls by this company →

Other recent Class II Drug recalls